ReviewTranslational lung cancer research2023

Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectives.

Mark G Kris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.